T-lymphocyte production of macrophage inflammatory protein-1α is critical to the recruitment of CD8+ T cells to the liver, lung, and spleen during graft-versus-host disease

Blood

Volumn 96, Issue 9, 2000, Pages 2973-2980

  Serody, J S ^a   Burkett, S E ^a   Panoskaltsis Mortari, A ^a   Ng Cashin, J ^a   McMahon, E ^a   Matsushima, G K ^a   Lira, S A ^a   Cook, D N ^a   Blazar, B R ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; LIVER; LUNG; LYMPHOCYTE COUNT; LYMPHOCYTE TRANSFUSION; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

EID: 0034330987     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.9.2973.h8002973_2973_2980     Document Type: Article

References (58)

1. Allogenic bone marrow transplantation for leukemias and aplastic anemia
2. The treatment of severe acquired aplastic anemia
3. Allogeneic bone marrow transplantation for leukemia
4. Marrow transplantation for acute myeloid leukemia
5. Adult acute leukemia
6. Bone marrow transplantation for chronic myelogenous leukemia
7. Stem cell transplantation in acute leukemia
8. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: Increased risk for relapse associated with T-cell depletion
9. Biology and treatment of chronic myeloid leukemia
10. Biology and treatment of adult acute lymphoblastic leukemia
11. Bone marrow transplantation for inherited diseases
12. Recent advances in graft-versus-host disease (GVHD) prevention
13. Prevention and treatment of graft-versus-host disease
14. GVHD: Overview on pathophysiology, incidence, clinical and biological features
15. Graft-versus-host disease
16. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice
17. CD4+ and CD8+ T cells each can utilize a perforin-dependent pathway to mediate lethal graft-versus-host disease in major histocompatibility complex-disparate recipients
18. Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation
19. The immunopathophysiology of acute graft-versus-host-disease
20. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution
21. The role of peptide specificity in MHC class I-restricted allogeneic responses
22. Human chemokines: An update
23. Chemokines and leukocyte traffic
24. Chemokines: A family of chemotactic cytokines
25. Leukocyte migration and activation by murine chemokines
26. The chemokines: Cytokines that direct leukocyte migration
27. The role of chemokines in inflammation
28. Chemokines
29. Old and new chemokines. Pharmacological regulation of chemokine production and receptor expression: Mini-review
30. Chemokines, inflammation and the immune system
31. Chemokines: Understanding their role in T-lymphocyte biology
32. Chemokines in allergic inflammation
33. Induction of chemokine gene expression during allogeneic skin graft rejection
34. Macrophage inflammatory protein-1 beta: A C-C chemokine in osteoarthritis
35. The role of chemokines in inflammatory joint disease
36. Lymphotactin: A key regulator of lymphocyte trafficking during acute graft rejection
37. Distinct patterns and kinetics of chemokine production regulate dendritic cell function
38. Murine T lymphocytes incapable of producing MIP-1α are impaired in causing GVHD across a Class I but not class II MHC barrier
39. Active participation of CCR5+ CD8+ T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease
40. A rapid and non-invasive selection of transgenic embryos before implantation using green fluorescent protein (GFP)
41. Engraftment of severe combined immune deficient (SCID) mice given allogeneic bone marrow (BM) via in utero or post-natal transfer
42. Profound atrophy of the bone marrow reflecting major histocompatibility complex class II-restricted destruction of stem cells by CD4+ cells
43. The role of host T-cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice
44. Graft-versus-host disease in experimental allogeneic bone marrow transplantation
45. Role of T-cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. II. Protective effects of L3T4+ cells in anti-class II GVHD
46. Human macrophage inflammatory protein α(MIP-1α) and MIP-1β chemokines attract distinct populations of lymphocytes
47. Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation
48. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation
49. Lung injury induced by alloreactive Th1 cells is characterized by host-derived mononuclear cell inflammation and activation of alveolar macrophages
50. The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cells infusion and potentiated by cyclophosphamide
51. Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production
52. CD8+ T cells are a biologically relevant source of MIP-1α in vivo
53. ICAMs redistributed by chemokines to cellular uropods as a mechanism for recruitment of T lymphocytes
54. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistem paradigm
55. The role of co-stimulation in regulation of chemokine receptor expression and HIV-1 infection in primary T lymphocytes
56. Regulation of C-C chemokine production by murine T cells by CD28/B7 costimulation
57. Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes
58. Prevention of graft-versus-host disease by inactivation of host antigen-presenting cells